MedPath

Nicardilex

Brand Name: Nicardilex

Generic Name: Nicardipine hydrochloride

Active
Registration Number

DRP-15060

Dosage Form

Solution for Injection (I.V.)

Issuance Date

April 1, 2024

Expiry Date

April 1, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1 mg/mL (20 mg/20 mL)
Packaging20 mL-net content USP Type I amber glass vial with grey glass vial butyl rubber stopper and aluminum seal with green plastic flip-off cap (Box of 1's)

Classification

C
Classification
Prescription (Rx) Drug
P
Pharmacologic
Calcium Channel Blocker (Dihydropyridine Derivative)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Nicardipine hydrochlorideActive
Monograph: Nicardipine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform